In vitro screening for population variability in chemical toxicity.
暂无分享,去创建一个
Ivan Rusyn | Fred A Wright | Oksana Kosyk | Min Jin Ha | I. Rusyn | F. Wright | O. Kosyk | M. Ha | Pamela K Ross | Shannon H O'Shea | John Schwarz | J. Schwarz
[1] Andrew Worth,et al. Metabolism: A Bottleneck in In Vitro Toxicological Test Development , 2006, Alternatives to laboratory animals : ATLA.
[2] Jing Shi,et al. Coupling cytotoxicity biomarkers with DNA damage assessment in TK6 human lymphoblast cells. , 2010, Mutation research.
[3] J. Bailar,et al. Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.
[4] Elliott Kieff,et al. Genetic Analysis of Human Traits In Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines , 2008, PLoS genetics.
[5] Thomas Hartung,et al. Are in vitro tests suitable for regulatory use? , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[6] Tom H. Pringle,et al. The human genome browser at UCSC. , 2002, Genome research.
[7] Ivan Rusyn,et al. Toxicogenetics: population-based testing of drug and chemical safety in mouse models. , 2010, Pharmacogenomics.
[8] V. Cheung,et al. Transcriptional response of lymphoblastoid cells to ionizing radiation. , 2003, Genome research.
[9] J. Cohen,et al. Generation of Epstein‐Barr Virus (EBV)–Immortalized B Cell Lines , 1991, Current protocols in immunology.
[10] J. Tracy,et al. Fingerprinting of cytochrome P450 and microsomal epoxide hydrolase gene expression in human blood cells. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[11] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[12] C. Miller,et al. CYP1A1 mRNA levels as a human exposure biomarker: use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes. , 1993, Carcinogenesis.
[13] K. Broman,et al. An Extension of the Regression of Offspring on Mid‐Parent to Test for Association and Estimate Locus‐Specific Heritability: The Revised ROMP Method , 2007, Annals of human genetics.
[14] Ruili Huang,et al. Characterization of diversity in toxicity mechanism using in vitro cytotoxicity assays in quantitative high throughput screening. , 2008, Chemical research in toxicology.
[15] R. Guigó,et al. Transcriptome genetics using second generation sequencing in a Caucasian population , 2010, Nature.
[16] Aldi Kraja,et al. Genome-wide discovery of loci influencing chemotherapy cytotoxicity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] Steven K. Gibb. Toxicity testing in the 21st century: a vision and a strategy. , 2008, Reproductive toxicology.
[18] N. Kudo,et al. Sex hormone-regulated renal transport of perfluorooctanoic acid. , 2002, Chemico-biological interactions.
[19] C. Sempoux,et al. Cytochrome P450 3A proteins are expressed in B lymphocytes but not in T lymphocytes. , 1999, Pharmacogenetics.
[20] Ivan Rusyn,et al. Systems biology and functional genomics approaches for the identification of cellular responses to drug toxicity. , 2008, Expert opinion on drug metabolism & toxicology.
[21] Zhaohui S. Qin,et al. A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.
[22] C. Elcombe,et al. Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[23] Jonathan I Levy,et al. Science and Decisions: Advancing Risk Assessment , 2010, Risk analysis : an official publication of the Society for Risk Analysis.
[24] Alison C Cullen,et al. The Application of Genetic Information for Regulatory Standard Setting Under the Clean Air Act: A Decision‐Analytic Approach , 2008, Risk analysis : an official publication of the Society for Risk Analysis.
[25] Nilanjan Chatterjee,et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries , 2010, Nature Genetics.
[26] Ruili Huang,et al. Compound Cytotoxicity Profiling Using Quantitative High-Throughput Screening , 2007, Environmental health perspectives.
[27] F. Collins,et al. Transforming Environmental Health Protection , 2008, Science.
[28] J. Watters,et al. CEPH individuals are representative of the European American population: implications for pharmacogenetics. , 2005, Pharmacogenomics.
[29] Melvin E Andersen,et al. Toxicity testing in the 21st century: bringing the vision to life. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[30] M. Rosen,et al. Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses. , 2007, Toxicology.
[31] G. Siest,et al. Transcription Factor and Drug-Metabolizing Enzyme Gene Expression in Lymphocytes from Healthy Human Subjects , 2008, Drug Metabolism and Disposition.
[32] M. Eileen Dolan,et al. A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity , 2007, Proceedings of the National Academy of Sciences.
[33] R. Judson,et al. The Toxicity Data Landscape for Environmental Chemicals , 2008, Environmental health perspectives.
[34] E. Cook,et al. Heritability and Linkage Analysis of Sensitivity to Cisplatin-Induced Cytotoxicity , 2004, Cancer Research.
[35] Paul D Jones,et al. Gene expression profiles in rat liver treated with perfluorooctanoic acid (PFOA). , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[36] P. Lam,et al. Differential expression of chicken hepatic genes responsive to PFOA and PFOS. , 2007, Toxicology.